Albert P. Rocchini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Albert P. Rocchini has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
John Q. Yang
From the Department of Pediatrics, Pediatric Cardiology Division
2 shared publicationsAmy Gokee
From the Division of Pediatric Cardiology, University of Michigan, Ann Arbor
1 shared publicationHui Z. Mao
From the Division of Pediatric Cardiology (A.P.R.), University of Michigan (Ann Arbor); Division of Pediatric Cardiology (P.M.), Department of Pediatrics, University of Minnesota (Minneapolis); and Division of Pediatric Cardiology (H.Z.M., A.J.R., K.B.), Children’s Memorial Hospital and Northwestern University, Chicago, Ill
1 shared publicationKeshava Babu
From the Division of Pediatric Cardiology (A.P.R.), University of Michigan (Ann Arbor); Division of Pediatric Cardiology (P.M.), Department of Pediatrics, University of Minnesota (Minneapolis); and Division of Pediatric Cardiology (H.Z.M., A.J.R., K.B.), Children’s Memorial Hospital and Northwestern University, Chicago, Ill
1 shared publicationMark A. Supiano
Department of Internal Medicine, Geriatrics Division, and Center on Aging, University of Utah, Salt Lake City, UT;3
1 shared publicationMarla J. Smith
The Department of Internal Medicine, Geriatrics Division, University of Michigan, Ann Arbor, MI; and the
1 shared publication
Latest Publications
- 7 February 2018
- Published by Springer Nature
- p. 47-60
Cardiovascular Influences on Blood Pressure
- 6 February 2017
- Published by Springer Nature
- p. 1-14
Cardiovascular Influences on Blood Pressure
- 29 May 2013
- Published by Springer Nature
- p. 43-55
Cardiovascular Influences on Blood Pressure
- 2 December 2010
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 50 (9) , 791-796
Angiotensin Receptor Blockers for the Treatment of Hypertension in Children
- 2 December 2010
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 50 (9) , 791-796
Angiotensin Receptor Blockers for the Treatment of Hypertension in Children
- 15 November 2010
- Published by Springer Nature
- p. 301-328
Childhood Obesity and Blood Pressure Regulation
- 15 November 2010
- Published by Springer Nature
- p. 301-328
Childhood Obesity and Blood Pressure Regulation
- 21 January 2010
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 12 (2) , 117-124
Serial Changes in Norepinephrine Kinetics Associated With Feeding Dogs a High‐Fat Diet
J Clin Hypertens (Greenwich). 2010;12:117–124. ©2009 Wiley Periodicals, Inc.The role of increased sympathetic nervous system (SNS) activity in the pathogenesis of obesity hypertension and insulin resistance is controversial. Eight dogs were instrumented and fed a high‐fat diet (HFD) for 6 weeks. Dogs were evaluated for changes in weight, blood pressure, insulin resistance, and norepinephrine (NE) kinetics using a two‐compartment model. The HFD resulted in weight gain, hypertension, and insulin resistance. During the 6 weeks of the HFD, although plasma NE concentration trended toward increasing (P=.09), SNS, assessed by NE kinetic studies, significantly increased (P=.009). Within 1 week of starting the HFD, NE release into the extravascular compartment (NE2) increased from 3.44±0.59 μg/mL to 4.87±0.80 μg/mL (P<.01) and this increase was maintained over the next 5 weeks of the HFD (NE2 at week 6 was 4.66±0.97 μg/mL). In addition to the increased NE2 there was also a significant increase in NE clearance (P=.04). There were significant correlations between the increase in NE2 and both the development of insulin resistance and hypertension. This study supports the hypothesis that activation of the SNS plays a pivotal role in the metabolic and hemodynamic changes that occur with weight gain induced by HFD.
- 21 January 2010
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 12 (2) , 117-124
Serial Changes in Norepinephrine Kinetics Associated With Feeding Dogs a High‐Fat Diet
J Clin Hypertens (Greenwich). 2010;12:117–124. ©2009 Wiley Periodicals, Inc.The role of increased sympathetic nervous system (SNS) activity in the pathogenesis of obesity hypertension and insulin resistance is controversial. Eight dogs were instrumented and fed a high‐fat diet (HFD) for 6 weeks. Dogs were evaluated for changes in weight, blood pressure, insulin resistance, and norepinephrine (NE) kinetics using a two‐compartment model. The HFD resulted in weight gain, hypertension, and insulin resistance. During the 6 weeks of the HFD, although plasma NE concentration trended toward increasing (P=.09), SNS, assessed by NE kinetic studies, significantly increased (P=.009). Within 1 week of starting the HFD, NE release into the extravascular compartment (NE2) increased from 3.44±0.59 μg/mL to 4.87±0.80 μg/mL (P<.01) and this increase was maintained over the next 5 weeks of the HFD (NE2 at week 6 was 4.66±0.97 μg/mL). In addition to the increased NE2 there was also a significant increase in NE clearance (P=.04). There were significant correlations between the increase in NE2 and both the development of insulin resistance and hypertension. This study supports the hypothesis that activation of the SNS plays a pivotal role in the metabolic and hemodynamic changes that occur with weight gain induced by HFD.
- 1 May 2004
- Published by Wolters Kluwer Health in Hypertension
- Vol. 43 (5) , 1011-1016
Hypertension and Insulin Resistance Are Not Directly Related in Obese Dogs
In dogs fed a high-fat diet, we determined whether there was a direct relation between obesity-induced insulin resistance and obesity-induced hypertension. Thirty-six adult mongrel dogs were chronically instrumented and assigned to receive either a high-fat diet alone (n=7) or a high-fat diet combined with a low-sodium diet plus furosemide (n=6), prazosin plus atenolol (n=7), clonidine (n=10), or aspirin (n=6). Blood pressure, heart rate, and body weight were measured daily. Insulin resistance was assessed with a single-dose euglycemic hyperinsulinemic clamp (2 mU · kg −1 · min −1 ) before and after 1, 3, and 6 weeks of the high-fat diet. The low-salt diet plus furosemide, prazosin plus atenolol, and clonidine treatments prevented the hypertension associated with feeding the dogs a high-fat diet. Only clonidine treatment totally prevented the development of insulin resistance, and high-dose aspirin, known to prevent insulin resistance by inhibition of the activity of IκB kinase-β, decreased the degree of insulin resistance by almost 70%. However, aspirin had no effect on the development of hypertension. We conclude that obesity-induced hypertension and obesity-induced insulin resistance are not directly related. In addition, there is a suggestion that insulin resistance in this experimental model is mediated through the central and or peripheral α 2 -adrenoceptors, whereas hypertension is mediated through the α 1 - and or β-adrenoceptors.
- 1 May 2004
- Published by Wolters Kluwer Health in Hypertension
- Vol. 43 (5) , 1011-1016
Hypertension and Insulin Resistance Are Not Directly Related in Obese Dogs
In dogs fed a high-fat diet, we determined whether there was a direct relation between obesity-induced insulin resistance and obesity-induced hypertension. Thirty-six adult mongrel dogs were chronically instrumented and assigned to receive either a high-fat diet alone (n=7) or a high-fat diet combined with a low-sodium diet plus furosemide (n=6), prazosin plus atenolol (n=7), clonidine (n=10), or aspirin (n=6). Blood pressure, heart rate, and body weight were measured daily. Insulin resistance was assessed with a single-dose euglycemic hyperinsulinemic clamp (2 mU · kg −1 · min −1 ) before and after 1, 3, and 6 weeks of the high-fat diet. The low-salt diet plus furosemide, prazosin plus atenolol, and clonidine treatments prevented the hypertension associated with feeding the dogs a high-fat diet. Only clonidine treatment totally prevented the development of insulin resistance, and high-dose aspirin, known to prevent insulin resistance by inhibition of the activity of IκB kinase-β, decreased the degree of insulin resistance by almost 70%. However, aspirin had no effect on the development of hypertension. We conclude that obesity-induced hypertension and obesity-induced insulin resistance are not directly related. In addition, there is a suggestion that insulin resistance in this experimental model is mediated through the central and or peripheral α 2 -adrenoceptors, whereas hypertension is mediated through the α 1 - and or β-adrenoceptors.
- 1 July 2002
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 17 (4) , 385-389
Pediatric hypertension 2001
During the past decade, there has been a surge of interest in childhood and adolescent hypertension. The current review summarizes work published during the past year in the following areas: prenatal and early postnatal causes of hypertension; new information on the genetics of childhood hypertension; the relation of obesity, insulin resistance, and diabetes to hypertension; the use of ambulatory blood pressure monitoring to evaluate childhood hypertension; and advances in drug therapy for children with hypertension. The information obtained during the past year has improved our understanding of the pathogenesis, diagnosis, and treatment of childhood hypertension.
- 1 July 2002
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 17 (4) , 385-389
Pediatric hypertension 2001
During the past decade, there has been a surge of interest in childhood and adolescent hypertension. The current review summarizes work published during the past year in the following areas: prenatal and early postnatal causes of hypertension; new information on the genetics of childhood hypertension; the relation of obesity, insulin resistance, and diabetes to hypertension; the use of ambulatory blood pressure monitoring to evaluate childhood hypertension; and advances in drug therapy for children with hypertension. The information obtained during the past year has improved our understanding of the pathogenesis, diagnosis, and treatment of childhood hypertension.
- 1 May 2002
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 17 (3) , 283-288
Pediatric cardiac catheterization
The publications of 2000 and 2001 stress how interventional pediatric cardiology has moved from angioplasty to device placement. This review summarizes the important articles during the past year that evaluated the safety and efficacy of atrial septal defect devices, patent ductus occluders, and stents to treat coarctation of the aorta. The past year has also seen the emergence of old technologies that have been modified and expanded for new applications. The three areas of old technology reviewed are (1) using balloon angioplasty to palliate low birth weight infants with critical coarctation, (2) using coronary interventions in the pediatric patient, and (3) using balloon pulmonary angioplasty to treat patients with chronic thromboembolic pulmonary hypertension. Finally, this review describes the development of a new interventional technique, transcatheter implantation of a pulmonary valve, and outlines how real-time MRI in the next decade likely will replace x-ray fluoroscopy as the primary diagnostic and interventional imaging tool for the pediatric cardiologist.
- 1 May 2002
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 17 (3) , 283-288
Pediatric cardiac catheterization
The publications of 2000 and 2001 stress how interventional pediatric cardiology has moved from angioplasty to device placement. This review summarizes the important articles during the past year that evaluated the safety and efficacy of atrial septal defect devices, patent ductus occluders, and stents to treat coarctation of the aorta. The past year has also seen the emergence of old technologies that have been modified and expanded for new applications. The three areas of old technology reviewed are (1) using balloon angioplasty to palliate low birth weight infants with critical coarctation, (2) using coronary interventions in the pediatric patient, and (3) using balloon pulmonary angioplasty to treat patients with chronic thromboembolic pulmonary hypertension. Finally, this review describes the development of a new interventional technique, transcatheter implantation of a pulmonary valve, and outlines how real-time MRI in the next decade likely will replace x-ray fluoroscopy as the primary diagnostic and interventional imaging tool for the pediatric cardiologist.
- 1 March 2000
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (3) , 332-342
Congenital Heart Surgery Nomenclature and Database Project: therapeutic cardiac catheter interventions
- 1 March 2000
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (3) , 332-342
Congenital Heart Surgery Nomenclature and Database Project: therapeutic cardiac catheter interventions